Notice ID: 4ec40975a68a448bbdd2c39309226e8cSpecial Notice
Q301--Notice of Intent to Sole Source - ExoDX Prostate Intelliscore Testing - 5 Year BPA
Archived on August 23, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM UTC−04:00
- Posted
- July 17, 2023
- Notice type
- Special Notice
Notice details
- Office
- 241-NETWORK CONTRACT OFFICE 01 (36C241)
- Last updated
- Dec 6, 2025
Identifiers
- Solicitation number
- 36C24123Q0897
- Notice ID
- 4ec40975a68a448bbdd2c39309226e8c
Description
The Department of Veterans Affairs (VISN1) hereby announces its intent to enter into a 5-year Sole Source Blanket Purchase Agreement (BPA) with EXOSOME DIAGNOSTICS, INC., 266 SECOND AVE, STE 200, WALTHAM, MA 02451-1167. This notice is not a request for quotes, but rather a notice of intent to conduct a sole source procurement in accordance with FAR 6.302-1; only one responsible source and no other supplies or services will satisfy agency requirements. The applicable North American Industry Classification System (NAICS) code is 621511, with a size standard of $36.5M. "ExoDx Prostate Test (Intelliscore) is a non-DRE urinebased liquid biopsy test indicated for men 50 years of age and older with a PSA 2 10 ng/mL being considered for an initial prostate biopsy. A patient-specific risk score is calculated based on a proprietary algorithm that combines the weighted expression of a three-gene signature in exosomal RNA. A score above the cut point is associated with an increased likelihood of GS 7 PCa on subsequent biopsy. Physicians can utilize the result in conjunction with other standard of care prognostic information to determine whether to proceed with a tissue biopsy." YR 1 Testing - CLIN 0001: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year YR 2 Testing - CLIN 0002: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year YR 3 Testing - CLIN 0003: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year YR 4 Testing - CLIN 0004: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year YR 5 Testing - CLIN 0005: Item: ExoDX Prostate (Intelliscore) Manufacturer: Exosome Diagnostics, Inc. SIN# 621-200 CPT Code: 0005U Estimated Qty: 360 Unit of Issue: Year Interested parties may identify their interests and capabilities by responding to this requirement by the due date listed on this notice. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination by the Government not to compete this proposed award upon response to this notice is solely within the discretion of the Government. No reimbursement for any cost connected with providing capability information will be provided.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36C24123Q0897- Special NoticeCurrentJul 17, 2023
Q301--Notice of Intent to Sole Source - ExoDX Prostate Intelliscore Testing - 5 Year BPA
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36C24123Q0897
Archive Date
Aug 23, 2023
Office Address
TOGUS, ME, 04330